REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,101,635 | -52.0% | 201,566 | -47.1% | 0.06% | -49.2% |
| Q3 2021 | $10,623,000 | +73.1% | 381,302 | +84.2% | 0.13% | +55.6% |
| Q2 2021 | $6,136,000 | +4.3% | 207,008 | -1.6% | 0.08% | -6.9% |
| Q1 2021 | $5,881,000 | -8.4% | 210,403 | -7.1% | 0.09% | -16.3% |
| Q4 2020 | $6,418,000 | -56.2% | 226,465 | -61.2% | 0.10% | -65.4% |
| Q3 2020 | $14,666,000 | -19.9% | 583,363 | -22.2% | 0.30% | -32.4% |
| Q2 2020 | $18,301,000 | +66.9% | 749,430 | +1.2% | 0.44% | +21.6% |
| Q1 2020 | $10,964,000 | +2.2% | 740,778 | +4.9% | 0.37% | +28.4% |
| Q4 2019 | $10,727,000 | +424.3% | 706,013 | +502.6% | 0.28% | +331.8% |
| Q1 2016 | $2,046,000 | -23.3% | 117,168 | +50.1% | 0.07% | -26.7% |
| Q4 2015 | $2,667,000 | +85.7% | 78,078 | +5.1% | 0.09% | +63.6% |
| Q3 2014 | $1,436,000 | -84.2% | 74,289 | -72.2% | 0.06% | -81.4% |
| Q2 2014 | $9,080,000 | +7.4% | 267,054 | -0.5% | 0.30% | +10.9% |
| Q1 2014 | $8,458,000 | – | 268,518 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |